| The future landscape of large language models in medicine J Clusmann, FR Kolbinger, HS Muti, ZI Carrero, JN Eckardt, NG Laleh, ... Communications Medicine 3 (1), 141, 2023 | 188 | 2023 |
| Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities M Kollareddy, E Dimitrova, KC Vallabhaneni, A Chan, T Le, KM Chauhan, ... Nature communications 6 (1), 7389, 2015 | 133 | 2015 |
| Coilin participates in the suppression of RNA polymerase I in response to cisplatin-induced DNA damage AS Gilder, PM Do, ZI Carrero, AM Cosman, HJ Broome, V Velma, ... Molecular biology of the cell 22 (7), 1070-1079, 2011 | 66 | 2011 |
| Coilin interacts with Ku proteins and inhibits in vitro non-homologous DNA end joining V Velma, ZI Carrero, AM Cosman, MD Hebert FEBS letters 584 (23), 4735-4739, 2010 | 39 | 2010 |
| β-TrCP-and casein kinase II-mediated degradation of cyclin F controls timely mitotic progression I Mavrommati, R Faedda, G Galasso, J Li, K Burdova, R Fischer, ... Cell reports 24 (13), 3404-3412, 2018 | 37 | 2018 |
| Phosphorylation regulates coilin activity and RNA association HJ Broome, ZI Carrero, HE Douglas, MD Hebert Biology open 2 (4), 407-415, 2013 | 34 | 2013 |
| Coilin phosphomutants disrupt Cajal body formation, reduce cell proliferation and produce a distinct coilin degradation product ZI Carrero, V Velma, HE Douglas, MD Hebert PLoS One 6 (10), e25743, 2011 | 33 | 2011 |
| Inheritance of the Golgi apparatus and cytokinesis are controlled by degradation of GBF1 R Magliozzi, ZI Carrero, TY Low, L Yuniati, C Valdes-Quezada, ... Cell reports 23 (11), 3381-3391. e4, 2018 | 16 | 2018 |
| Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation ZI Carrero, M Kollareddy, KM Chauhan, G Ramakrishnan, LA Martinez Oncotarget 7 (11), 12554, 2016 | 15 | 2016 |
| Coilin levels modulate cell cycle progression and γH2AX levels in etoposide treated U2OS cells V Velma, ZI Carrero, CB Allen, MD Hebert FEBS letters 586 (19), 3404-3409, 2012 | 14 | 2012 |
| Regression-based Deep-Learning predicts molecular biomarkers from pathology slides OSM El Nahhas, CML Loeffler, ZI Carrero, M van Treeck, FR Kolbinger, ... Nature Communications 15 (1), 1253, 2024 | 13 | 2024 |
| From text to tables: a local privacy preserving large language model for structured information retrieval from medical documents IC Wiest, D Ferber, J Zhu, M Van Treeck, SK Meyer, R Juglan, ZI Carrero, ... medRxiv, 2023.12. 07.23299648, 2023 | 6 | 2023 |
| Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and … CML Loeffler, OSM El Nahhas, HS Muti, T Seibel, D Cifci, M van Treeck, ... medRxiv, 2023 | 5 | 2023 |
| Phosphorylation regulates coilin activity and RNA association. Biol Open 2013; 2: 407-15; PMID: 23616925 HJ Broome, ZI Carrero, HE Douglas, MD Hebert | 5 | |
| Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity AA Wurm, S Brilloff, S Kolovich, S Schäfer, E Rahimian, V Kufrin, M Bill, ... Cell Reports Medicine 4 (10), 2023 | 4 | 2023 |
| Direct Image to Subtype Prediction for Brain Tumors using Deep Learning KJ Hewitt, CML Löffler, HS Muti, AS Berghoff, C Eisenlöffel, M van Treeck, ... Neuro-Oncology Advances, vdad139, 2023 | 3 | 2023 |
| A Good Feature Extractor Is All You Need for Weakly Supervised Learning in Histopathology G Wölflein, D Ferber, AR Meneghetti, OSM El Nahhas, D Truhn, ... arXiv preprint arXiv:2311.11772, 2023 | 2 | 2023 |
| Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer S Chatterji, JM Niehues, M van Treeck, CML Loeffler, OL Saldanha, ... NPJ Breast Cancer 9 (1), 91, 2023 | 2 | 2023 |
| Automated curation of large‐scale cancer histopathology image datasets using deep learning L Hilgers, N Ghaffari Laleh, NP West, A Westwood, KJ Hewitt, P Quirke, ... Histopathology, 2024 | | 2024 |
| Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions J Schöpf, S Uhrig, CE Heilig, KS Lee, T Walther, A Carazzato, ... Nature Communications 15 (1), 51, 2024 | | 2024 |
Jakob Nikolas Kather, MD, MScElse Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, GermanyVerified email at tu-dresden.de
